Clinical Investigation of MYIBDDiet App Developed for Inflammatory Bowel Disease (IBD) Patients to Self-manage Their Diet
Launched by UNIVERSITY OF ALBERTA · Nov 8, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new app called MYIBDDiet, which is designed to help people with Inflammatory Bowel Disease (IBD) learn more about healthy eating. The main goal is to find out if using this app is easier and more helpful for patients compared to the usual dietary advice they might get from their doctors. Participants in the study will be asked to use the app for a month and share their experiences through surveys to see if it makes a positive difference in their eating habits.
To participate, you need to be at least 18 years old and have a confirmed diagnosis of IBD, but you should not be experiencing a flare-up of your condition. There are some health issues that would exclude you from joining, such as certain digestive problems or being on a special diet for your IBD. If you join, you can expect to use the app regularly and provide feedback on how user-friendly and effective it is in helping you manage your diet. This study is an exciting opportunity to see if a digital tool can improve the lives of people with IBD through better nutrition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. ≥18 years
- • 2. Able to provide informed consent
- • 3. Established diagnosis of IBD determined by treating physician
- • 4. Not in acute flare
- • 5. Not pregnant
- • 6. Willing and able to comply with all required study procedures
- Exclusion Criteria:
- • 1. Short bowel syndrome
- • 2. High ostomy output
- • 3. Intestinal strictures
- • 4. Pregnancy or breastfeeding
- • 5. Malnutrition (evaluated by Canadian Nutrition Screening Tool (CNST) )
- • 6. Conditions requiring dietary restrictions (e.g. Celiac disease, kidney disease, diabetes, eosinophilic esophagitis)
- • 7. Have other conditions that may require low fibre diet such as irritable bowel syndrome, gastroparesis.
- • 8. Currently on a therapeutic diet
- • 9. Have ever participated in another therapeutic diet study
- • 10. Already on a diet for IBD or using diet tool for IBD (e.g. Mediterranean or anti-inflammatory diet)
- • 11. Active malignancy
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported